Lee, Yong-Seok
(Department of Nuclear Medicine, Seoul National University Hospital)
Cho, Yong-Hyun (Department of Nuclear Medicine, Seoul National University Hospital) Lee, Hong-Jae (Department of Nuclear Medicine, Seoul National University Hospital) Lee, Yun-Sang (Institute of Radiation Medicine, Seoul National University Hospital) Jeong, Jae Min (Department of Nuclear Medicine, Seoul National University Hospital) |
1 | Barthel H, Sabri O. Florbetaben to trace amyloid-beta in the Alzheimer brain by means of PET. J Alzheimers Dis. 2011;26 Suppl 3:117-21. DOI |
2 | Murphy MP, LeVine H, 3rd. Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19(1):311-23. DOI |
3 | Mosconi L, Brys M, Glodzik-Sobanska L, De Santi S, Rusinek H, de Leon MJ. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol. 2007;42(1-2):129-38. DOI |
4 | Okamura N, Harada R, Furukawa K, Furumoto S, Tago T, Yanai K, et al. Advances in the development of tau PET radiotracers and their clinical applications. Ageing Res Rev. 2016;30:107-13. DOI |
5 | Cohen AD, Klunk WE. Early detection of Alzheimer's disease using PiB and FDG PET. Neurobiol Dis. 2014;72 Pt A:117-22. DOI |
6 | Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68(3):319-29. DOI |
7 | Jureus A, Swahn BM, Sandell J, Jeppsson F, Johnson AE, Johnstrom P, et al. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J Neurochem. 2010;114(3):784-94. DOI |
8 | Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry. 2012;83(9):923-6. DOI |